News24 | SA Gets R520m to Buy the Twice-a-Year Anti-HIV jab... but There’s a Snag

SA gets R520 million to buy the twice-a-year anti-HIV jab – but there’s a snag – The Mail & Guardian

South Africa has accepted an offer of just over $29 million (about R520 million) from the Global Fund to Fight Aids, TB and Malaria to buy the twice-a-year anti-HIV jab, lenacapavir, that research shows could help to end Aids in the country, says health department spokesperson, Foster Mohale.  But there’s a snag.  The country isn’t getting extra money from the fund to buy the medicine; it has to use cash from a grant that it has already been awa…

News24 | SA gets R520m to buy the twice-a-year anti-HIV jab... but there’s a snag

South Africa has accepted an offer of just over $29 million (about R520 million) from the Global Fund to Fight Aids, TB and Malaria to buy the twice-a-year anti-HIV jab, lenacapavir, that research shows could help to end Aids in the country, says health department spokesperson Foster Mohale.

South Africa Gets R520 Million to Buy the Twice-a-Year Anti-HIV Jab - But There's a Snag

SA has accepted an offer of just over R520-million from the Global Fund to Fight Aids, TB and Malaria to buy the twice-a-year anti-HIV jab, lenacapavir. Research shows the shot could help end Aids in the country. But there's a snag.